Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2012
03/22/2012US20120070382 Fluorescent conjugated polymers with a bodipy-based backbone and uses thereof
03/22/2012US20120070374 Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides
03/22/2012US20120067744 Impurity Detection Device and Method
03/22/2012US20120067742 Linker, impedance biochip, and method of quantitatively detecting target analyte in fluid sample using the biochip
03/22/2012US20120067723 Temperature Control of Chemical Detection System
03/22/2012US20120067722 Biosensor for measuring biomaterial
03/22/2012US20120067370 Semi-automated heat exchanger tube cleaning assembly and method
03/22/2012US20120067111 Bearing, arrangement for determining properties of a lubricant in a bearing and method for determining properties of a lubricant in a bearing
03/22/2012US20120066875 Method and system for grading bedding fabric
03/22/2012DE102010047283B4 Untersuchungsverfahren/Screeningverfahren unter Einbeziehung von lebenden Geweben des Blutgefäß-Systems Investigation procedure / screening processes involving living tissues of the vascular system
03/22/2012DE102010046912A1 Verfahren zum Nachweis von fettlöslichen Vitaminen A method for the detection of fat-soluble vitamins
03/22/2012DE102010046047A1 Substanz zur gerichtsverwertbaren Markierung Substance to be used in court marking
03/22/2012DE102010045599A1 Method for rapid test of neuroborreliosis, comprises dripping fluid from cerebrospinal fluid to a portion of a test strip and subsequently reading an optical indicator in a different section of the test strip
03/22/2012DE102010041166A1 Sensoranordnung Sensor array
03/22/2012DE102010037578A1 Device for measuring mechanical properties of viscoelastic sample i.e. vital soft tissue, of internal organ, has measuring head securely held at sample by fixator even when maximum permissible pressure is applied to measuring chamber
03/22/2012DE102009043537B4 Verfahren und Anordnung zur Bestimmung von Zell-Vitalitäten Method and apparatus for determining cell viabilities
03/22/2012DE102009041885B4 Separation von Mesenchymalen Stammzellen Mesenchymal stem cells separation of
03/22/2012DE102008012760B4 Vorrichtung zur elektrischen Kontaktierung biologischer Zellen An apparatus for electrically contacting biological cells
03/22/2012DE10036907B4 Verfahren zur Herstellung einer Beschichtung auf einem mit Gold bedampften Glassubstrat, Beschichtung hergestellt nach diesem Verfahren und deren Verwendung A process for producing a coating on a vapor-coated with gold glass substrate, the coating produced by this method and their use
03/22/2012CA2811538A1 Na+/mg2+ exchanger
03/22/2012CA2811501A1 Inhibitor of hmgb protein-mediated immune response activation, and screening method
03/22/2012CA2811107A1 Prolyl endopeptidase probes
03/22/2012CA2811015A1 Molecular diagnostic test for cancer
03/22/2012CA2811009A1 Raman spectroscopy for bioprocess operations
03/22/2012CA2811003A1 A highly sensitive monoclonal antibody residual detection assay
03/22/2012CA2810831A1 Method for non-invasive analysis of a substance concentration within a body
03/22/2012CA2810778A1 Preparation of a molecular recognition element
03/22/2012CA2810725A1 Methods of use and kit for measurement of lipopolysaccharide with a time resolved fluorescence based assay
03/22/2012CA2810601A1 Analyte measurement method and system with hematocrit compensation
03/22/2012CA2810568A1 Method for the diagnosis and/or prognosis of inflammatory states
03/22/2012CA2810390A1 Monoclonal antibodies and detection methods for enzymes that confer resistance to 2,4-dichlorophenoxyacetic acid
03/22/2012CA2810305A1 Electrical or electronic apparatus, in particular welding machine or battery charger
03/22/2012CA2809877A1 Method and device for isolating cells from heterogeneous solution using microfluidic trapping vortices
03/21/2012EP2431746A1 Platelet aggregation assays
03/21/2012EP2431745A2 Method for using cfh or apoh as a biochemical marker for diagnosis of acute myeloid leukemia
03/21/2012EP2431744A1 In vitro diagnostic method for infant eye allergy
03/21/2012EP2431743A2 Cancer specific glycans and use thereof
03/21/2012EP2431742A1 Preparation of a Molecular Recognition Element
03/21/2012EP2431741A1 Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation)
03/21/2012EP2431740A1 Method for measurement of equol in biological sample by immunoassay, kit for the measurement, and method for determination of equol production ability of subject
03/21/2012EP2431739A1 Method for the detection and/or quantification of the interaction of platelets with interaction partners
03/21/2012EP2431738A1 Method for screening osteopontin inhibitor and inhibitor prepared thereby
03/21/2012EP2431730A1 Device for discriminating between different fluids based on their refractive index
03/21/2012EP2431482A2 Anti-cancer drug screening method using ror
03/21/2012EP2431480A2 Methods and compositions for increasing the stress resistance of cells and organisms
03/21/2012EP2431478A1 Methods and compositions for expressing negative-sense viral RNA in canine cells
03/21/2012EP2431463A1 Test agent for visceral obesity and use thereof
03/21/2012EP2431460A2 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof
03/21/2012EP2431391A1 Novel monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
03/21/2012EP2431387A1 A raft deficient yeast expression system for the production of recombinant membrane proteins
03/21/2012EP2431377A1 Modified L-nucleic acids
03/21/2012EP2431054A2 Human tumor necrosis factor delta and epsilon
03/21/2012EP2431053A1 Novel glycosylated peptide target in neoplastic cells
03/21/2012EP2431029A2 Method of inhibiting prostate cancer cell proliferation
03/21/2012EP2430454A1 Imaging and evaluating embryos, oocytes, and stem cells
03/21/2012EP2430453A1 Cmybp-c and mlc2 as diagnostic markers of cardiac injury
03/21/2012EP2430452A1 Carcinoma diagnosis and treatments, based on odc1 genotype
03/21/2012EP2430451A1 Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
03/21/2012EP2430450A1 Cybp as a marker of lung cancer
03/21/2012EP2430449A1 Use of the gtpase rab27b to diagnose and treat poor prognosis estrogen-receptor-positive breast cancer
03/21/2012EP2430448A1 Detection of changes in cell populations and mixed cell populations
03/21/2012EP2430447A1 Method for characterizing and/or determining samples
03/21/2012EP2430446A2 Methods and compositions for analyte detection
03/21/2012EP2430445A2 System and methods for rapid identification and/or characterization of a microbial agent in a sample
03/21/2012EP2430444A1 Method for identifying inhibitors against dengue virus
03/21/2012EP2430443A1 Biomarkers for determining sensitivity of breast cancer cells to her2-targeted therapy
03/21/2012EP2430442A1 Platform technologies for spontaneously occurring diseases
03/21/2012EP2430440A1 Environmental control of fluid samples, calibration, and detection of concentration levels
03/21/2012EP2430437A1 Apparatus and methods for separating and analyzing components in fluids
03/21/2012EP2430430A1 Method for reducing loss of electromagnetic radiation in detection applications
03/21/2012EP2430425A1 High sensitivity plasmonic structures for use in surface plasmon resonance sensors and method of fabrication thereof
03/21/2012EP2430420A1 Closure, containing apparatus, and method of using same
03/21/2012EP2430193A1 Markers for detection of gastric cancer
03/21/2012EP2430191A1 Phosphodiesterase 4d7 as prostate cancer marker
03/21/2012EP2430190A1 Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer
03/21/2012EP2430189A1 Phosphodiesterase 9a as prostate cancer marker
03/21/2012EP2430179A1 Detection method
03/21/2012EP2430178A1 Methods and kits for measuring toxicity and oxidative stress in live cells
03/21/2012EP2430146A1 Method and apparatus for the analysis and identification of molecules
03/21/2012EP2430049A1 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
03/21/2012EP2429957A1 Tagged scale inhibitors
03/21/2012EP2429954A1 Real-time, on-line analysis for the quantification of total haloacetic acid and trihalomethane species in drinking water supplies
03/21/2012EP2429712A1 Disposal separator/concentrator device and method of use
03/21/2012EP2429565A2 Peptides and aptamers for targeting of neuron or nerves
03/21/2012EP2329262B1 Filter system for extracorporeal depletion of activated polymorphonuclear leukocytes (pmns)
03/21/2012EP2323764B1 Apparatus for effecting chemical assays
03/21/2012EP2286238B1 Methods of distinguishing between glutamine formed by cataplerosis or proteolysis
03/21/2012EP2176432B1 Diagnosing a disease and staging cancer by membrane electrophoresis
03/21/2012EP2171450B1 Adamts4 as a blood biomarker and therapeutic target for chronic renal failure
03/21/2012EP2167531B1 Streptococcus pneumoniae pilus antigens
03/21/2012EP2148934B1 Matrix marker model and methods for assessing and treating rheumatoid arthritis
03/21/2012EP2096432B1 Method for measuring 1,5-anhydroglucitol in whole blood
03/21/2012EP2093194B1 Fluorescent labeling agent and fluorescent labeling method
03/21/2012EP2044212B1 Methods for identifying patients with increased risk of an adverse cardiovascular event
03/21/2012EP2023138B1 Method and system for screening the receptor-ligand binding in live cell
03/21/2012EP1989551B1 Method of detecting or diagnosing of a neurodegenerative disease or condition
03/21/2012EP1952142B1 Dissolution composition for examining drug solubility
03/21/2012EP1889055B1 Test system
03/21/2012EP1853629B1 Human ring specific bnp antibodies
03/21/2012EP1825257B1 Diagnostic system for determining substance concentrations in liquid samples